CY1120528T1 - Παραγωγα βενζοφουρανο-2-σουλφοναμιδιου ως τροποποιητες υποδοχεων χημειοκινων - Google Patents

Παραγωγα βενζοφουρανο-2-σουλφοναμιδιου ως τροποποιητες υποδοχεων χημειοκινων

Info

Publication number
CY1120528T1
CY1120528T1 CY20181100816T CY181100816T CY1120528T1 CY 1120528 T1 CY1120528 T1 CY 1120528T1 CY 20181100816 T CY20181100816 T CY 20181100816T CY 181100816 T CY181100816 T CY 181100816T CY 1120528 T1 CY1120528 T1 CY 1120528T1
Authority
CY
Cyprus
Prior art keywords
benzofuran
modifiers
chemokine receptors
sulphonamide derivatives
derivatives
Prior art date
Application number
CY20181100816T
Other languages
English (en)
Inventor
Haiqing Yuan
Richard L. Beard
Xiaoxia Liu
John E. Donello
Veena Viswanath
Michael E. Garst
Original Assignee
Allergan, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allergan, Inc. filed Critical Allergan, Inc.
Publication of CY1120528T1 publication Critical patent/CY1120528T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/82—Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Η παρούσα εφεύρεση αφορά σε νέα παράγωγα βενζοφουρανο-2-σουλφοναμιδίου, διαδικασίες παραγωγής τους, φαρμακευτικές συνθέσεις που τα περιέχουν και τη χρήση τους ως φαρμακευτικά προϊόντα, με το ρόλο του τροποποιητή υποδοχέων χημειοκινών.
CY20181100816T 2012-03-01 2018-08-07 Παραγωγα βενζοφουρανο-2-σουλφοναμιδιου ως τροποποιητες υποδοχεων χημειοκινων CY1120528T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261605300P 2012-03-01 2012-03-01
PCT/US2013/028607 WO2013130962A1 (en) 2012-03-01 2013-03-01 Benzofuran- 2 - sulfonamide derivatives as chemokine receptor modulators

Publications (1)

Publication Number Publication Date
CY1120528T1 true CY1120528T1 (el) 2019-07-10

Family

ID=47902352

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20181100816T CY1120528T1 (el) 2012-03-01 2018-08-07 Παραγωγα βενζοφουρανο-2-σουλφοναμιδιου ως τροποποιητες υποδοχεων χημειοκινων

Country Status (12)

Country Link
US (4) US8815915B2 (el)
EP (2) EP2820010B1 (el)
AU (2) AU2013225815B2 (el)
CA (1) CA2866078C (el)
CY (1) CY1120528T1 (el)
DK (2) DK2820010T3 (el)
ES (2) ES2791534T3 (el)
HU (2) HUE038700T2 (el)
PL (2) PL2820010T3 (el)
PT (2) PT3345899T (el)
SI (1) SI2820010T1 (el)
WO (2) WO2013130958A1 (el)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2791534T3 (es) * 2012-03-01 2020-11-04 Allergan Inc Derivados de benzofuran-2-sulfonamida como moduladores del receptor de quimiocinas
WO2014159657A1 (en) * 2013-03-12 2014-10-02 Allergan, Inc. Pyridinyl and pyrimidinyl sulfonamide derivatives as chemokine receptor modulators
US20150152080A1 (en) * 2013-12-02 2015-06-04 Allergan, Inc. Benzothiophene sulfonamides derivatives as chemokine receptor modulators

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003099773A1 (en) 2002-05-24 2003-12-04 Millennium Pharmaceuticals, Inc. Ccr9 inhibitors and methods of use thereof
US20070021466A1 (en) * 2002-11-18 2007-01-25 Solomon Ungashe CCR2 inhibitors and methods of use thereof
US7420055B2 (en) 2002-11-18 2008-09-02 Chemocentryx, Inc. Aryl sulfonamides
US7393873B2 (en) 2003-07-02 2008-07-01 Merck & Co., Inc. Arylsulfonamide derivatives
MXPA06001550A (es) * 2003-08-08 2006-09-04 Johnson & Johnson Compuestos de 2-(quinoxalin-5-ilsulfonilamino)-benzamida como moduladores de a colecistocinina 2.
US7622583B2 (en) 2005-01-14 2009-11-24 Chemocentryx, Inc. Heteroaryl sulfonamides and CCR2
US7931909B2 (en) 2005-05-10 2011-04-26 Allergan, Inc. Ocular therapy using alpha-2 adrenergic receptor compounds having enhanced anterior clearance rates
GB0524786D0 (en) 2005-12-05 2006-01-11 Glaxo Group Ltd Compounds
US8519135B2 (en) 2006-07-14 2013-08-27 Chemocentryx, Inc. Heteroaryl sulfonamides and CCR2/CCR9
WO2008008374A2 (en) 2006-07-14 2008-01-17 Chemocentryx, Inc. Ccr2 inhibitors and methods of use thereof
ATE498615T1 (de) 2006-07-14 2011-03-15 Chemocentryx Inc Triazolylphenylbenzensulfonamide
DK2175859T3 (da) 2007-07-12 2012-06-18 Chemocentryx Inc Kondenserede heteroarylpyridyl- og phenylbenzen-sulfonamider som ccr2-modulatorer til behandling af inflammation
TWI440638B (zh) 2007-10-30 2014-06-11 Otsuka Pharma Co Ltd 雜環化合物及其藥學組成物
EP2955173B1 (en) * 2010-12-16 2017-10-04 Allergan, Inc. 1,2-bis-sulfonamide derivatives as chemokine receptor modulators
WO2012082568A1 (en) * 2010-12-16 2012-06-21 Allergan, Inc. Phosphorous derivatives as chemokine receptor modulators
EP2791121B1 (en) * 2011-12-12 2016-08-03 Allergan, Inc. Benzisothiazol-3(1h)-one-5-sulfonyl derivatives as chemokine receptor modulators
ES2791534T3 (es) * 2012-03-01 2020-11-04 Allergan Inc Derivados de benzofuran-2-sulfonamida como moduladores del receptor de quimiocinas
WO2014159657A1 (en) * 2013-03-12 2014-10-02 Allergan, Inc. Pyridinyl and pyrimidinyl sulfonamide derivatives as chemokine receptor modulators

Also Published As

Publication number Publication date
DK2820010T3 (en) 2018-08-06
US20140329813A1 (en) 2014-11-06
EP2820010B1 (en) 2018-05-09
ES2791534T3 (es) 2020-11-04
AU2013225815A1 (en) 2014-09-25
US20130231339A1 (en) 2013-09-05
WO2013130958A1 (en) 2013-09-06
PL3345899T3 (pl) 2020-07-27
US9416120B2 (en) 2016-08-16
EP3345899A1 (en) 2018-07-11
US8927544B2 (en) 2015-01-06
EP3345899B1 (en) 2020-02-19
SI2820010T1 (sl) 2018-11-30
US8815915B2 (en) 2014-08-26
US9550746B2 (en) 2017-01-24
DK3345899T3 (da) 2020-05-11
CA2866078A1 (en) 2013-09-06
US20150218119A1 (en) 2015-08-06
CA2866078C (en) 2018-01-02
EP2820010A1 (en) 2015-01-07
AU2018200226A1 (en) 2018-01-25
PT2820010T (pt) 2018-10-01
AU2013225815B2 (en) 2017-10-12
PT3345899T (pt) 2020-05-20
US20130231338A1 (en) 2013-09-05
PL2820010T3 (pl) 2018-11-30
AU2018200226B2 (en) 2019-09-19
ES2683046T3 (es) 2018-09-24
HUE038700T2 (hu) 2018-11-28
HUE049728T2 (hu) 2020-10-28
WO2013130962A1 (en) 2013-09-06

Similar Documents

Publication Publication Date Title
CY1119200T1 (el) Νεα παραγωγα βενζιμιδαζολιου ως ερ4 ανταγωνιστες
CY1121452T1 (el) Παραγωγα πουρινης για τη θεραπευτικη αντιμετωπιση ιικων λοιμωξεων
CY1120969T1 (el) Παραγωγα κινοξαλινης χρησιμα ως τροποποιητες fgfr κινασης
EA201890126A1 (ru) Новые бициклические производные, способ их получения и фармацевтические композиции, содержащие их
CY1117956T1 (el) N3-αντικατεστημενα-n1-sulfonyl-5-fluoropyrimidinone παραγωγα
CY1123953T1 (el) Καθυστερημενης απελευθερωσης συνθεσεις λινακλοτιδης
CY1119110T1 (el) Ρυθμιστες ρ2χ7
EA201401292A2 (ru) Новые тиенопиримидиновые производные, способ их получения и фармацевтические композиции, содержащие их
CY1117563T1 (el) Αντισωματα κατα her3 και χρησεις αυτων
EA201890124A1 (ru) Новые гидроксикислотные производные, способ их получения и фармацевтические композиции, содержащие их
CY1118735T1 (el) Παραγωγα βενζιμιδαζολο-προλινης
CY1116100T1 (el) Παραγωγα πυριμιδινονης, η παρασκευη τους και η φαρμακευτικη τους χρηση
EA201892838A1 (ru) Новые пиперидинильные производные, способ их получения и фармацевтические композиции, содержащие их
EA201890123A1 (ru) Новые аминокислотные производные, способ их получения и фармацевтические композиции, содержащие их
CY1119151T1 (el) Ν-(4-(αζαϊνδαζολ-6-υλ)-φαινυλ)-σουλφοναμιδiα και η χρηση τους ως φαρμακα
EA201400833A1 (ru) Новые индолизиновые соединения, способ их получения и фармацевтические композиции, содержащие их
CY1120204T1 (el) Αμορφη στερεα διασπορα για χρηση σε θεραπεια καρκινου του εγκεφαλο
CY1119047T1 (el) Υποκατεστημενα βενζαμιδια με δραστικοτητα εναντι υποδοχεων ερ4
CY1116775T1 (el) Παραγωγα πυριμιδονης ως αναστολεις της ιστικης τρανσγλουταμινασης
EA201600124A1 (ru) Новые индолизиновые соединения, способ их получения и фармацевтические композиции, содержащие их
CY1115590T1 (el) Σουλφοξιμινυποκατεστημενα παραγωγα ανιλινοπυριμιδινης ως cdk-αναστολεις, η παραγωγη αυτων και η χρηση αυτων ως φαρμακευτικα μεσα
CY1117210T1 (el) Παραγωγα 2-οξο-1-ιμιδαζολιδινυλ ιμιδαζοθειαδιαζολης
CY1117288T1 (el) Παραγωγα 2-οξο-1-πυρρολιδινυλ ιμιδαζοθειαδιαζολης
TR201821285T4 (tr) CCR3 antagonisti içeren farmasötik formülasyonlar.
SV2018005760A (es) Derivados de aminotiazol utiles como agentes antiviricos